Monday, April 15, 2019

Celling Biosciences Buys ThermiGen

Austin-based Celling Biosciences said on Friday that it has acquired ThermiGen, the aesthetic device division of Spanish pharmaceutical company Almirall

The story you have requested is only available to paid members of the TEXASTECHPULSE web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.